Literature DB >> 31667153

Uncomplicated type A intramural hematoma: surgery or conservative approach?-surgery.

Arturo Evangelista1,2, Giuliana Maldonado2, Sergio Moral3, Jose Rodriguez-Palomares1.   

Abstract

Entities:  

Year:  2019        PMID: 31667153      PMCID: PMC6785490          DOI: 10.21037/acs.2019.07.04

Source DB:  PubMed          Journal:  Ann Cardiothorac Surg        ISSN: 2225-319X


× No keyword cloud information.
  10 in total

Review 1.  Optimal initial treatment and clinical outcome of type A aortic intramural hematoma: a clinical review.

Authors:  Chung-Ben Kan; Rei-Yeuh Chang; Jen-Ping Chang
Journal:  Eur J Cardiothorac Surg       Date:  2008-03-17       Impact factor: 4.191

2.  Spanish Acute Aortic Syndrome Study (RESA). Better diagnosis is not reflected in reduced mortality.

Authors:  Arturo Evangelista; Ferran Padilla; Jordi López-Ayerbe; Francisco Calvo; José Manuel López-Pérez; Violeta Sánchez; César Morís; Rubén Fernández-Tarrío; José A San Román; Daniel Saura; Francisco Nistal; Josep M Alegret; Pastora Gallego; Río Aguilar
Journal:  Rev Esp Cardiol       Date:  2009-03       Impact factor: 4.753

3.  Acute intramural hematoma of the aorta: a mystery in evolution.

Authors:  Arturo Evangelista; Debabrata Mukherjee; Rajendra H Mehta; Patrick T O'Gara; Rossella Fattori; Jeanna V Cooper; Dean E Smith; Jae K Oh; Stuart Hutchison; Udo Sechtem; Eric M Isselbacher; Christoph A Nienaber; Linda A Pape; Kim A Eagle
Journal:  Circulation       Date:  2005-02-14       Impact factor: 29.690

4.  Intramural hematoma of the aorta: predictors of progression to dissection and rupture.

Authors:  Yskert von Kodolitsch; Susanne K Csösz; Dietmar H Koschyk; Ilka Schalwat; Roger Loose; Matthias Karck; Christoph Dieckmann; Rossella Fattori; Axel Haverich; Jürgen Berger; Thomas Meinertz; Christoph A Nienaber
Journal:  Circulation       Date:  2003-03-04       Impact factor: 29.690

5.  Prognostic value of clinical and morphologic findings in short-term evolution of aortic intramural haematoma. Therapeutic implications.

Authors:  Arturo Evangelista; Rosa Dominguez; Carmen Sebastia; Armando Salas; Gaieta Permanyer-Miralda; Gustavo Avegliano; Zamira Gomez-Bosh; Teresa Gonzalez-Alujas; Herminio Garcia del Castillo; Jordi Soler-Soler
Journal:  Eur Heart J       Date:  2004-01       Impact factor: 29.983

6.  Usefulness of the initial noninvasive imaging study to predict the adverse outcomes in the medical treatment of acute type A aortic intramural hematoma.

Authors:  Jong-Min Song; Hyun-Sook Kim; Jae-Kwan Song; Duk-Hyun Kang; Myeong-Ki Hong; Jae-Joong Kim; Seong-Wook Park; Seung-Jung Park; Tae-Hwan Lim; Meong-Gun Song
Journal:  Circulation       Date:  2003-09-09       Impact factor: 29.690

7.  Outcomes of patients with acute type a aortic intramural hematoma.

Authors:  Jae-Kwan Song; Ji Hye Yim; Jung-Min Ahn; Dae-Hee Kim; Joon-Won Kang; Taek Yeon Lee; Jong-Min Song; Suk Jung Choo; Duk-Hyun Kang; Cheol Hyun Chung; Jae Won Lee; Tae-Hwan Lim
Journal:  Circulation       Date:  2009-11-09       Impact factor: 29.690

8.  Outcomes and management of type A intramural hematoma.

Authors:  Harleen K Sandhu; Akiko Tanaka; Kristofer M Charlton-Ouw; Rana O Afifi; Charles C Miller; Hazim J Safi; Anthony L Estrera
Journal:  Ann Cardiothorac Surg       Date:  2016-07

9.  International heterogeneity in diagnostic frequency and clinical outcomes of ascending aortic intramural hematoma.

Authors:  Jamie M Pelzel; Alan C Braverman; Alan T Hirsch; Kevin M Harris
Journal:  J Am Soc Echocardiogr       Date:  2007-07-05       Impact factor: 5.251

10.  Treatment patterns and their outcomes of acute aortic intramural hematoma in real world: multicenter registry for aortic intramural hematoma.

Authors:  Yoon-Jung Choi; Jang-Won Son; Sang-Hee Lee; Ung Kim; Dong-Gu Shin; Young-Jo Kim; Seung-Ho Hur; Chang-Wook Nam; Yun-Kyeong Cho; Bong-Ryul Lee; Byung-Chun Jeong; Jin-Bae Lee; Jae-Kean Ryu; Hun-Sik Park; Jang-Hoon Lee; Se-Yong Jang; Jong-Seon Park
Journal:  BMC Cardiovasc Disord       Date:  2014-08-19       Impact factor: 2.298

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.